Type 2 Diabetes Trial, Recruiting (NCT05370014)

Type 2 Diabetes Trial, Recruiting NCT05370014 Sponsor: University of South Carolina Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT05370014 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For COVID-19 survivors:

People who identify as African American
People of any gender (male or female)
People living in a medically underserved area or a designated rural area of South Carolina
People aged 18 years or older
People who were hospitalised, visited an emergency room, or visited an urgent care clinic due to COVID-19 at any point since March 11th, 2020
People who have previously been diagnosed with one or more of the following conditions: type 2 diabetes, high blood pressure, heart disease, chronic kidney disease, or stroke (diagnosed more than 3 months ago)

For care partners (people who support a survivor):

People of any gender (male or female)
People aged 18 years or older
People who live on the same property or in the same community as the survivor, preferably within 40 miles of them
People who are the main unpaid provider of care or social support for the survivor at home

Who may not be able to join:

Survivors or care partners who are currently enrolled in a related clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gayenell S Magwood, PhD, University of South Carolina

Phone: 8037779160

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05370014

Sponsor: University of South Carolina

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: 8037779160

More information: https://clinicaltrials.gov/study/NCT05370014

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For COVID-19 survivors:

People who identify as African American
People of any gender (male or female)
People living in a medically underserved area or a designated rural area of South Carolina
People aged 18 years or older
People who were hospitalised, visited an emergency room, or visited an urgent care clinic due to COVID-19 at any point since March 11th, 2020
People who have previously been diagnosed with one or more of the following conditions: type 2 diabetes, high blood pressure, heart disease, chronic kidney disease, or stroke (diagnosed more than 3 months ago)

For care partners (people who support a survivor):

People of any gender (male or female)
People aged 18 years or older
People who live on the same property or in the same community as the survivor, preferably within 40 miles of them
People who are the main unpaid provider of care or social support for the survivor at home

Who may not be able to join:

Survivors or care partners who are currently enrolled in a related clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of South Carolina

Registry

ClinicalTrials.gov

Start date

3 January 2023

Est. completion

30 May 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in patient-reported outcomes measurement information system (PROMIS) Global Health Scale

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov